MAPT and Alzheimer disease: In addition to the emerging role of plasma Aβ as a blood biomarker for AD, plasma measurements of tau phosphorylated at threonine 231 (p-tau231), p-tau181, p-tau217, and potentially others have shown promise in diagnostic capacity [62–64].